ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS)

CAPS Rating: 4 out of 5

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases.

Recs

0
Player Avatar pchop123 (79.82) Submitted: 5/22/2013 3:53:48 PM : Outperform Start Price: $20.35 ISIS Score: +7.04

more upside

Featured Broker Partners


Advertisement